Cluster news
Kaluga Pharmaceutical Cluster: over 60 Companies, 31 Development Projects, RUR 19 billion Revenue in 2015
PharmEvolution international forum was held in Obninsk on March 29, 2016.
Interpharmglass: New Member of Kaluga Pharmaceutical Cluster
MMTI, Hong Kong, an international investment company, is to invest in construction of Interpharmglass new primary pharmaceutical packaging plant in Kaluga Region.
A unique module of clean rooms according to GMP standards was opened in the training center of the Kaluga pharmaceutical cluster
On September 2 in the building of a new academic building of the National Research Nuclear University MEPhI in Obninsk, the grand opening of the module cleanrooms of the Center for the practical training the employees in the pharmaceutical industry was held.
Pfizer and Novamedika to invest in pharmaceutical plant in Kaluga Region
Pfizer is to invest in construction of a production facility in Kaluga Region. The project is being implemented by Novamedika, a Russian pharmaceutical company. Apart from that, Pfizer plans to transfer licenses for production of over 30 pharmaceuticals to the new plant.
Russian group «Mir-Pharm» to be located in the Special Economic Zone "Kaluga"
On June 30, 2016 the Governor of Kaluga region Anatoly Artamonov and the general director of the OOO «Mir-Pharm» Iskandar Ismaguilov signed a Memorandum of understanding for the investment project of building a plant to produce high-tech pharmaceutical substances and solid dosage forms.
Two members of Kaluga pharmaceutical cluster was awarded the most prestigious award «the Platinum Ounce» in the pharmaceutical market
The results of the All-Russia annual open contest "the Platinum Ounce - 2015" were announced at a solemn ceremony on April 21, 2016.
The first in Russia manufacture of test-systems for identification will be launched in Obninsk
Now up to 98% of the Russian market of this production is occupied by foreign manufacturers
FRP Advisory Council of the Ministry of industry and trade approved a loan for the development of new import-substituting production in the Kaluga region in the amount of 300 million rubles.
The company "the Field-farm" plans to produce a complex salt and amino acid solutions for the correction of protein deficiency of blood in pre - and postoperative conditions, as well as solutions for blood purification in acute and chronic renal failure, which is produced in Russia in small quantities.
Kaluga Engineering Center: Pharmaceutical Industry Developers Point of Attraction
The sitting of the Coordination Council for Pharmaceutical Cluster Development under Kaluga Region Governor took place on April 22, 2016 in Obninsk. The attendees discussed the new conditions for government support provision, Kaluga Region’s innovative infrastructure and other acute issues.
In Obninsk launched a unique complex of proton therapy
March 9 in the framework of the innovation forum "Pharmabase 2016" held a press-conference dedicated to the start-up of the medical proton synchrotron complex in MRRC them. A. F. Tsyb.